Home > Insider Trading > Filing (0000899243-21-017470)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1630627	Treace Medical Concepts Inc.	TMCI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1185249	R John Treace	C/O Treace Medical Concepts, Inc. 203 Fort Wade Rd., Suite 150 Ponte Vedra FL 32081		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-04-27	427,875	$0.00	2,707,856	No	4	C	Indirect	John R. Treace and Ginger D. Treace JTTEN
Common Stock	Disposition	2021-04-27	401,250	$17.00	2,306,606	No	4	S	Indirect	John R. Treace and Ginger D. Treace JTTEN

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	John R. Treace and Ginger D. Treace JTTEN
No	4	S	Indirect	John R. Treace and Ginger D. Treace JTTEN

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Acquisiton	2021-04-27	9,906	$0.00	9,906	$0.00
Common Stock	Series A Preferred Stock	Disposition	2021-04-27	427,875	$0.00	427,875	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,906			No	4	J	Indirect
0			No	4	C	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	535,000	Indirect	As Trustee of the JTT Trust forDescendants dated October 5, 2020
Common Stock	568,437	Indirect	As Trustee of the TWT Irrevocable Trust dated September 30, 2020

Footnotes

Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.
These shares were sold by the Reporting Person as a selling stockholder in conjuction with the Issuer's Form S-1 filing, Registration Number 333-254863. The offering closed on April 27, 2021. The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters.
The Reporting Person disclaims beneficial ownership of shares held in trusts for which he is a co-trustee.
The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.